Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning

被引:709
作者
Weaver, Terri E.
Maislin, Greg
Dinges, David F.
Bloxham, Thomas
George, Charles F. P.
Greenberg, Harly
Kader, Gihan
Mahowald, Mark
Younger, Joel
Pack, Allan I.
机构
[1] Univ Penn, Sch Nursing, Biobehav & Hlth Sci Div, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Ctr Sleep & Resp Neurobiol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Psychiat, Div Sleep & Chronobiol, Philadelphia, PA 19104 USA
[4] Sleep Med Ctr Kansas, Wichita, KS USA
[5] Univ Western Ontario, London, ON, Canada
[6] N Shore Long Isl Jewish Hlth Syst, New Hyde Pk, NY USA
[7] St Lukes Hosp, Chesterfield, MO USA
[8] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA
[9] Bon Secours Holy Family Reg Hlth Syst, Altoona, PA USA
[10] Univ Penn, Sch Med, Dept Med, Div Sleep Med, Philadelphia, PA 19104 USA
关键词
obstructive sleep apnea; dose response; nightly duration; daytime sleepiness; quality of life; CPAP; adherence; daily functioning; alertness;
D O I
10.1093/sleep/30.6.711
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Study Objectives: Evidence suggests that, to maintain treatment effects, nasal continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea (OSA) needs to be used every night. What remains unknown is the nightly duration of use required to normalize functioning. This study, employing probit analyses and piecewise regression to estimate doseresponse functions, estimated likelihoods of return to normal levels of sleepiness and daily functioning relative to nightly duration of CPAP. Design: Multicenter, quasi-experimental study. Setting: Seven sleep centers in the United States and Canada. Participants: Patients with severe OSA (total cohort n = 149; the numbers of included participants from 85 - 120, depending on outcome analyzed.) Interventions: CPAP. Measurements and Results: Before treatment and again after 3 months of therapy, participants completed a day of testing that included measures of objective and subjective daytime sleepiness and functional status. There were significant differences in mean nightly CPAP duration between treatment responders and nonresponders across outcomes. Thresholds above which further improvements were less likely relative to nightly duration of CPAP were identified for Epworth Sleepiness Scale score (4 hours), Multiple Sleep Latency Test (6 hours), and Functional Outcomes associated with Sleepiness Questionnaire (7.5 hours). A linear dose-response relationship (P < 0.01) between increased use and achieving normal levels was shown for objective and subjective daytime sleepiness, but only up to 7 hours use for functional status. Conclusions: Our analyses suggest that a greater percentage of patients will achieve normal functioning with longer nightly CPAP durations, but what constitutes adequate use varies between different outcomes. Keywords: Obstructive sleep apnea, dose response, nightly duration, daytime sleepiness, quality of life, CPAP, adherence, daily functioning, alertness
引用
收藏
页码:711 / 719
页数:9
相关论文
共 39 条
[1]   Non-invasive detection of respiratory effort-related arousals (RERAs) by a nasal cannula/pressure transducer system [J].
Ayappa, I ;
Norman, RG ;
Krieger, AC ;
Rosen, A ;
O'Malley, RL ;
Rapoport, DM .
SLEEP, 2000, 23 (06) :763-771
[2]   PERSISTENT NEUROPSYCHOLOGICAL DEFICITS AND VIGILANCE IMPAIRMENT IN SLEEP-APNEA SYNDROME AFTER TREATMENT WITH CONTINUOUS POSITIVE AIRWAYS PRESSURE (CPAP) [J].
BEDARD, MA ;
MONTPLAISIR, J ;
MALO, J ;
RICHER, F ;
ROULEAU, I .
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 1993, 15 (02) :330-341
[3]   Patterns of performance degradation and restoration during sleep restriction and subsequent recovery: a sleep dose-response study [J].
Belenky, G ;
Wesensten, NJ ;
Thorne, DR ;
Thomas, ML ;
Sing, HC ;
Redmond, DP ;
Russo, MB ;
Balkin, TJ .
JOURNAL OF SLEEP RESEARCH, 2003, 12 (01) :1-12
[4]   Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure [J].
Campos-Rodriguez, F ;
Peña-Griñan, N ;
Reyes-Nuñez, N ;
De la Cruz-Moron, I ;
Perez-Ronchel, J ;
De la Vega-Gallardo, F ;
Fernandez-Palacin, A .
CHEST, 2005, 128 (02) :624-633
[5]  
Carskadon M, 1982, SLEEP, V5, P67
[6]   GUIDELINES FOR THE MULTIPLE SLEEP LATENCY TEST (MSLT) - A STANDARD MEASURE OF SLEEPINESS [J].
CARSKADON, MA ;
DEMENT, WC ;
MITLER, MM ;
ROTH, T ;
WESTBROOK, PR ;
KEENAN, S .
SLEEP, 1986, 9 (04) :519-524
[7]  
Chesson AL, 1997, SLEEP, V20, P406
[8]   Neurobehavioral consequences of arousals [J].
Chugh, DK ;
Weaver, TE ;
Dinges, DE .
SLEEP, 1996, 19 (10) :S198-S201
[9]   Effects of modafinil on sustained attention performance and quality of life in OSA patients with residual sleepiness while being treated with nCPAP [J].
Dinges, DF ;
Weaver, TE .
SLEEP MEDICINE, 2003, 4 (05) :393-402
[10]   Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome [J].
Engleman, HM ;
Martin, SE ;
Deary, IJ ;
Douglas, NJ .
THORAX, 1997, 52 (02) :114-119